Resolution Therapeutics Limited is a clinical‑stage biotechnology company developing regenerative ma Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2026-02-11 | £25.0M |
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| SYNCONA PORTFOLIO LIMITEDCORP | SERIES A PREFERRED, SERIES B PREFERRED | 63,590,694 | 89.3% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
77 more shareholders on file , sign up free to see.
Companies with the most similar business descriptions.
Capital raised per employee divides the equity RESOLUTION THERAPEUTICS LIMITED raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. RESOLUTION THERAPEUTICS LIMITED has 5 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
THE GROWTH SHARES, SHALL NOT CONFER ANY RIGHT TO RECEIVE NOTICE OF AND TO ATTEND, SPEAK OR VOTE AT ANY GENERAL MEETING OF THE COMPANY OR VOTE ON PROPOSED WRITTEN RESOLUTIONS OF THE COMPANY, OR OTHERWISE ENTITLE THE HOLDERS OF THEM TO CONSTITUTE AN ELIGIBLE MEMBER FOR THE PURPOSES OF PROPOSED WRITTEN RESOLUTIONS OF THE COMPANY. THE HOLDERS OF THE GROWTH SHARES ARE NOT ELIGABLE FOR DIVIDEND PAYMENTS. ON A DISTRIBUTION OF ASSETS ON A LIQUIDATION OR A RETURN OF CAPITAL (OTHER THAN A CONVERSION, REDEMPTION OR PURCHASE OF SHARES) THE SURPLUS ASSETS OF THE COMPANY REMAINING AFTER PAYMENT OF ITS LIABILITIES SHALL BE DISTRIBUTED (TO THE EXTENT THAT THE COMPANY IS LAWFULLY PERMITTED TO DO SO): (I) FIRST IN PAYING TO THE HOLDERS OF THE DEFERRED SHARES IF ANY A TOTAL OF £1.00 FOR THE ENTIRE CLASS OF DEFERRED SHARES (WHICH PAYMENT SHALL BE DEEMED SATISFIED BY PAYMENT TO ANY ONE HOLDER OF DEFERRED SHARES); (II) SECOND, IN PAYING TO EACH HOLDER OF SERIES A PREFERRED SHARES AN AMOUNT EQUAL TO THE SUBSCRIPTION PRICE OF EACH SERIES A PREFERRED SHARE HELD (THE " PREFERENCE AMOUNT") (PROVIDED THAT IF THERE ARE INSUFFICIENT ASSETS TO PAY AN AMOUNT EQUAL TO THE PREFERENCE AMOUNT IN RESPECT OF ALL OF THE SERIES A PREFERRED SHARES, THE REMAINING ASSETS SHALL BE PAID TO THE HOLDERS OF THE SERIES A PREFERRED SHARES PRO RATA TO THE PREFERENCE AMOUNT OF THE SERIES A PREFERRED SHARES HELD BY THEM); AND (III) THIRD, IN PAYING THE BALANCE OF THE SURPLUS ASSETS (IF ANY) TO THE HOLDERS OF THE SERIES A PREFERRED SHARES, ORDINARY SHARES AND GROWTH SHARES PRO RATA (AS IF THE SERIES A PREFERRED SHARES, ORDINARY SHARES AND GROWTH SHARES CONSTITUTED ONE AND THE SAME CLASS). THE GROWTH SHARES ARE NOT REDEEMABLE.
THE SERIES B PREFERRED SHARES SHALL CONFER ON EACH HOLDER THEREOF THE RIGHT TO RECEIVE NOTICE OF AND TO ATTEND, SPEAK AND VOTE AT ALL GENERAL MEETINGS OF THE COMPANY AND TO RECEIVE AND VOTE ON PROPOSED WRITTEN
THE SERIES B PREFERRED SHARES SHALL CONFER ON EACH HOLDER THEREOF THE RIGHT TO RECEIVE NOTICE OF AND TO ATTEND, SPEAK AND VOTE AT ALL GENERAL MEETINGS OF THE COMPANY AND TO RECEIVE AND VOTE ON PROPOSED WRITTEN RESOLUTIONS OF THE COMPANY. NO DIVIDEND SHALL BE DECLARED OR PAID TO THE HOLDERS OF SHARES IN RESPECT OF ANY FINANCIAL YEAR WITHOUT INVESTOR MAJORITY CONSENT AND ANY SUCH DIVIDEND MAY THEN BE PAID TO THE HOLDERS OF THE PREFERRED SHARES AND THE ORDINARY SHARES PROVIDED ALWAYS THAT
These are the directors and secretaries who have left RESOLUTION THERAPEUTICS LIMITED. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.